Related Experiment Video
Updated: May 12, 2026

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
Published on: November 16, 2011
Leptin therapy, insulin sensitivity, and glucose homeostasis
Gilberto Paz-Filho1, Claudio Mastronardi, Ma-Li Wong
1Department of Translational Medicine, The John Curtin School of Medical Research, The Australian National University, Canberra, Australia.
Leptin, a hormone regulating food intake, also improves glucose-insulin homeostasis independently of body weight. Understanding leptin
Area of Science:
- Endocrinology
- Metabolic Research
- Neuroscience
Background:
- Glucose homeostasis is regulated by insulin and leptin.
- Both hormones influence food intake and adiposity centrally in humans.
- Leptin exerts effects on glucose-insulin homeostasis independent of body weight.
Purpose of the Study:
- To review the interactions between leptin and insulin.
- To summarize leptin's effects on glucose metabolism.
- To highlight leptin's therapeutic potential for diabetes and insulin resistance.
Main Methods:
- Review of existing literature on leptin and insulin.
- Analysis of central and peripheral effects of leptin.
- Examination of leptin's impact on glycemia, insulinemia, and insulin resistance.
Main Results:
- Leptin has beneficial effects on glucose-insulin metabolism.
- These effects include decreased glycemia and insulinemia.
- Leptin reduces insulin resistance through central and peripheral actions.
Conclusions:
- Leptin plays a crucial role in glucose homeostasis.
- Leptin's actions in the hypothalamus, pancreas, muscles, and liver are key.
- Further understanding can lead to leptin-based therapies for metabolic disorders.
More Related Videos
06:16White and Brown Adipose Grafts: An Approach to Correct Reproductive, Metabolic, and Renal Deficits in Black and Tan Brachyury (BTBR) Obese Mice
Published on: September 9, 2025
08:47Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
Published on: December 7, 2017
Related Concept Videos
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Dipeptidyl Peptidase 4 Inhibitors
Oral Hypoglycemic Agents: Biguanides and Glitazones
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are co-secreted in...
Oral Hypoglycemic Agents: Glinides
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...